In F5M2cells, miR-183 inhibits the metastasis of osteosarcoma, the most common primary malignancy of bones, and influences the migration and invasion of osteosarcomas by targeting Ezrin [48,49]. The gene discussed is EZR; the disease is osteosarcoma.